BMO Capital analyst Evan Seigerman maintains Bristol-Myers Squibb (NYSE:BMY) with a Market Perform and maintains $48 price target.
BMO Capital Maintains Market Perform on Bristol-Myers Squibb, Maintains $48 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.